In conclusion, the strength of this study lies in the use of Western blotting, immunohistochemistry, and ELISA to demonstrate the similarities and differences in the expression of AGP in cancer tissues and adjacent normal tissues in patients with breast cancer. Here, ATP5MK is linked to breast carcinoma.